Travere Therapeutics Inc (TVTX)
$50.39 -0.36% Close Oct 30, 2026 Live
Travere Therapeutics stock today
Travere Therapeutics closed at $50.39 on October 30, 2026, down 0.36% on the day. Over the past year it returned +69.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $4.69 billion.
$40.00$60.00
NovJan 2026MarMayJulSep
| Period | TVTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -14.4% | -0.9% |
| 3 months | -12.0% | +2.1% |
| Year to date | +31.9% | +11.7% |
| 1 year | +69.9% | +12.4% |
| 3 years | +645.4% | +88.5% |
| 5 years | +74.9% | +76.0% |
Key statistics
- Market value
- $4.69B
- Forward P/E
- 14.8
- Price / sales
- 7.9
- 52-week range
- $26.79 to $67.52
- Next report
- Nov 2, 2026
About Travere Therapeutics
Develops and commercializes pharmaceutical treatments for rare and specialized kidney and metabolic disorders.
Sector: Health Care
More on Travere Therapeutics
- Financials: revenue, earnings and segmentsRevenue +110% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $2,651 today
No forecast, no recommendation. This page describes Travere Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.